IDPH--Positive preliminary results for pivotal trial of ID

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID

An SI Board Since June 1996

Posts	SubjectMarks	Bans	Symbol
1762	27	0	IDPH

Emcee: Roudy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1662	One Year Cost of Treatment of Rituximab Compared to Fludarabine for Relapsed or	Bob L	-	5/19/1999
1661	Here is the link to the ASCO abstract for the fludarabine + rituxan combo. asco	Bob L	-	5/19/1999
1660	5/17/99 - Studies Show Additional Promise for Non-Hodgkin's Lymphoma Drug;	Roudy	-	5/18/1999
1659	Lehmans latest research report raises price target. Need Acrobat Reader to view	Roudy	-	4/27/1999
1658	Posting from the Yahoo thread. Anyone have an insight on the manufacturing of B	Roudy	-	4/23/1999
1657	Looks like more of the same, Bob. We need to know if GNE thinks that C2B8 will	scaram(o)uche	-	4/19/1999
1656	Well Rick, can you make anything out of this: TITLE: Growth inhibition of CD2	Bob L	-	4/19/1999
1655	Bob: Sometime soon (I promise), I'm going to cruise through the excerpts t	scaram(o)uche	-	4/19/1999
1654	Thanks for those links, PB.	Bob L	-	4/3/1999
1653	Does anyone know what happen today? Why the quick dip down to $47 and the back	guido leone	-	4/1/1999
1652	Bob, take a look at this link for some context on anti-CD40L: Message 8632656	Pseudo Biologist	-	3/31/1999
1651	In other news, IDEC Pharmaceuticals Begins Phase II Study Of IDEC-131 In Pati	Bob L	-	3/31/1999
1650	Here is an interesting bit of speculation about the market relationship between	Bob L	-	3/31/1999
1649	Lehman reiterates buy rating and target price of $59. Says drop in price is a b	Roudy	-	3/24/1999
1648	*Oncolym with Cu67 instead of I131. Also, how about IDEC buys TCLN and gets so	Maurice Winn	1	3/23/1999
1647	(posting from Yahoo)salomon...reiterates...target $60 by: RU2L8 671 of	Roudy	-	3/22/1999
1646	>> This drug sounds remarkably similar to THP-dox, a tumor homing pe	scaram(o)uche	-	3/15/1999
1645	(Posted on Yahoo) According to Bloomberg reports out this week: Coulter Pharma	Roudy	-	3/15/1999
1644	Bob, Thanks for posting the table information here. IDPH thread is pretty quiet	Roudy	-	3/15/1999
1643	Table 4. Tumor Response and Duration in Nine Previously Treated Patients: Last	Bob L	-	3/15/1999
1642	Table 3. Response to Therapy Response CR PR	Bob L	-	3/15/1999
1641	Richard, here is another piece of the article we were discussing on the cltr th	Bob L	-	3/15/1999
1640	I have not heard of any such rumor. Looking at the price action of the stock. I	Roudy	-	3/4/1999
1639	Does anyone know about the talk on the street about a big partner walking away	jpginvest	-	3/4/1999
1638	Thanks for posting that information. It is very informative. Also posted on the	Roudy	-	2/17/1999

Go to reply# or date (mm/dd/yy):